The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 26, 2019

Filed:

Apr. 01, 2016
Applicant:

Alienor Farma, Pessac, FR;

Inventors:

Corrado Spadafora, Rome, IT;

Ilaria Sciamanna, Rome, IT;

Chiara De Luca, Rome, IT;

Paola Sinibaldi-Vallebona, Rome, IT;

Fiorella Guadagni, Rome, IT;

Gerald Schumann, Dreieich, DE;

Enrico Garaci, Rome, IT;

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); C07K 16/30 (2006.01); C07K 16/32 (2006.01); C07K 16/40 (2006.01); A61K 39/395 (2006.01); G01N 33/574 (2006.01); C07K 16/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); C07K 16/18 (2013.01); C07K 16/32 (2013.01); C07K 16/40 (2013.01); G01N 33/57419 (2013.01); G01N 33/57496 (2013.01); C07K 2317/14 (2013.01); G01N 2333/46 (2013.01);
Abstract

The present disclosure relates to a monoclonal antibody specifically binding to human Long Interspersed Element-1 ORF2 encoded protein (L1-ORF2p) obtained from hybridoma chA1, and derivatives and uses thereof, including for prediction of response of cancer patients to NNRTI treatments. It also relates to a method for early detection of cell transformation in pre-neoplastic tissues of a human subject, comprising detecting in cells of a pre-neoplastic tissue sample from said subject the expression of L1-ORF2p, wherein the expression of L1-ORF2p indicates the presence of cell transformation in said pre-neoplastic tissues. It also relates to a method for detecting progression of colon adenoma in a human subject suffering from colon adenoma, based on detection of an increase of L1-ORF2p expression.


Find Patent Forward Citations

Loading…